8-K: Aya Healthcare to Acquire Cross Country Healthcare for $615 Million in All-Cash Deal

Aya Healthcare will acquire Cross Country Healthcare for $18.61 per share in cash, valuing the transaction at approximately $615 million.

Summary

• Aya Healthcare has agreed to acquire Cross Country Healthcare for $18.61 per share in an all-cash transaction.
• The deal is valued at approximately $615 million.
• This represents a 67% premium to Cross Country's closing price on December 3, 2024, and a 68% premium to the 30-day volume-weighted average trading price.
• The acquisition aims to combine the strengths of both companies, expanding Aya's services to include Cross Country's clinical services in non-clinical settings.
• The combined entity will offer a full suite of market-leading technology, including vendor management, float pool technology, and predictive analytics.
• Cross Country and Aya will operate as separate brands, supporting each other's clients with increased access to candidates.
• The transaction is expected to close in the first half of 2025, pending stockholder and regulatory approvals.
• Cross Country will become a private company after the acquisition, and its stock will be delisted from the NASDAQ.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the significant premium offered to Cross Country shareholders and the strategic benefits of the merger. The language used is optimistic about the future of the combined company.

Positives

• The acquisition provides a significant 67% premium to Cross Country's closing price on December 3, 2024, offering immediate value to stockholders.
• The merger will diversify Aya's service offerings to include Cross Country's clinical services in non-clinical settings.
• Clients will benefit from a full suite of market-leading technology and a seamless solution for vendor management.
• Clinicians will have access to a wider array of opportunities and efficiencies.
• Employees of both companies will benefit from shared best practices and opportunities for personal growth.
• The combined company will be better positioned to solve complex staffing challenges and deliver high-quality patient care.

Negatives

• Cross Country will be delisted from the NASDAQ and become a private company.
• There is a risk that regulatory approvals may not be obtained or may be subject to unanticipated conditions.
• The transaction could lead to a diversion of management time from ongoing business operations.
• There is a risk that the announcement of the transaction could have adverse effects on the market price of Cross Country's stock.
• The transaction could have an adverse effect on the ability of Cross Country to retain customers and key personnel.

Risks

• The timing of the transaction is subject to regulatory and stockholder approvals, which may cause delays.
• There is a risk that a condition of closing may not be satisfied or that the closing might not occur.
• The transaction could lead to a diversion of management time on transaction-related issues.
• The announcement of the transaction could have adverse effects on the market price of Cross Country's stock.
• The transaction could have an adverse effect on the ability of Cross Country to retain customers and key personnel.
• There is a risk of potential litigation relating to the merger.
• Worldwide economic or political changes could affect the demand for Cross Country's services.
• Changes in marketplace conditions, such as alternative modes of healthcare delivery, could impact the company.
• Disruptions in the global credit and financial markets could pose challenges.

Future Outlook

The combined company aims to provide enhanced value to healthcare systems, schools, clinicians, and non-clinical professionals, with a focus on innovation and exceptional service. Cross Country will operate as a separate brand under Aya, with John A. Martins continuing as President and CEO of Cross Country.

Management Comments

• Alan Braynin, president and Chief Executive Officer of Aya, stated that they are excited to join forces with Cross Country and bring more innovative solutions and exceptional service across the industry.
• John A. Martins, President and Chief Executive Officer of Cross Country, said that the transaction will deliver significant and immediate value to their stockholders and enhance services for their clients.
• Kevin C. Clark, Co-Founder and Chairman of Cross Country, expressed confidence that the combined company will be better positioned to achieve their goals long into the future.

Industry Context

This acquisition reflects a trend of consolidation in the healthcare staffing industry, where companies are seeking to expand their service offerings and geographic reach. The combination of Aya's tech-enabled platform with Cross Country's established clinical services aims to create a more comprehensive solution for healthcare providers.

Comparison to Industry Standards

• The 67% premium offered to Cross Country shareholders is significantly higher than typical acquisition premiums in the healthcare staffing sector, suggesting a strong desire by Aya to secure the deal.
• The all-cash nature of the deal is also notable, as it provides immediate liquidity to Cross Country shareholders, unlike deals involving stock swaps.
• The combined entity will compete with other large healthcare staffing firms such as AMN Healthcare and CHG Healthcare, but with a broader range of services and a stronger technology platform.
• The focus on technology integration and data analytics aligns with industry trends towards more efficient and data-driven workforce management solutions.

Management Changes

Stakeholder Impact

• Shareholders of Cross Country will receive a significant premium for their shares.
• Clients of both companies will benefit from a broader range of services and technology.
• Clinicians will have access to more job opportunities and flexibility.
• Employees of both companies will have opportunities for growth and development.

Next Steps

• Cross Country will file a proxy statement with the SEC.
• Cross Country will hold a special meeting of stockholders to vote on the merger agreement.
• The companies will seek regulatory approvals.
• The transaction is expected to close in the first half of 2025.

Key Dates

Keywords

Aya Healthcare, Cross Country Healthcare, acquisition, merger, healthcare staffing, workforce solutions, clinical services, travel nursing, locum tenens, vendor management, stockholders, premium